The UK Peritoneal Dialysis Market was valued at $138 Million in 2026 and projected to reach to $179.6 Million by 2031, representing a compound annual growth rate of 5.4%. The UK peritoneal dialysis market is positioned for steady growth driven by NHS initiatives promoting home-based renal therapies and increasing patient awareness of peritoneal dialysis benefits.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
The UK peritoneal dialysis market is valued at $138.0 million in 2026 and is projected to reach $179.6 million by 2031, with a steady CAGR of 5.4% throughout the forecast period.
The UK's National Health Service provides robust renal care services and actively promotes home-based dialysis therapies, creating a supportive environment for peritoneal dialysis adoption and patient accessibility.
Increasing adoption of home-based dialysis solutions in the UK reflects patient preference for flexible, independent treatment options that reduce hospital visits and improve quality of life for renal patients.
The UK's well-established healthcare system, advanced medical facilities, and trained nephrology workforce support the expansion and standardization of peritoneal dialysis services across regions.
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
|
|
A global leader in kidney care offering a comprehensive peritoneal dialysis portfolio, including automated peritoneal dialysis (APD) cyclers, PD solutions, consumables, and digital therapy management platforms. The company supports home-based dialysis through extensive training, remote monitoring, and a strong global clinical network across North America, Europe, Asia Pacific, Latin America, and the Middle East. | Improves treatment efficiency and patient independence through advanced APD technologies. Enhances therapy adherence, reduces infection risks with standardized protocols, and enables remote patient monitoring for better clinical outcomes and quality of life. |
|
|
A dedicated kidney care company providing a broad portfolio of APD systems, CAPD solutions, PD cyclers, dialysis solutions, transfer sets, and digital renal care technologies. Vantive focuses on expanding access to home dialysis through connected care platforms, clinician education, and patient support programs across developed and emerging markets. | Enables personalized home dialysis, improves treatment continuity, and enhances patient comfort. Connected care solutions support remote monitoring, optimize therapy adherence, and improve long-term clinical outcomes while reducing healthcare resource utilization. |
|
|
Offers advanced PD access products including catheters, transfer sets, connectors, needles, and infection-prevention technologies used in peritoneal dialysis procedures. The company's products support safe catheter placement and standardized PD practices across hospitals and home-care settings. | Minimizes catheter-related complications and peritonitis risk while improving procedural safety and reliability. Supports efficient PD initiation and maintenance, enhancing patient safety and reducing treatment interruptions. |
|
|
Provides minimally invasive vascular access technologies, guidewires, introducers, catheters, and surgical products that facilitate safe placement and management of peritoneal dialysis catheters. The company leverages advanced medical device expertise to support renal access procedures worldwide. | Enhances procedural success, improves catheter placement accuracy, and reduces access-related complications. Reliable device performance supports broader adoption of peritoneal dialysis and improves clinician confidence during implantation procedures. |
|
|
One of the world's leading dialysis service providers offering comprehensive home-based peritoneal dialysis programs supported by patient education, clinical training, remote monitoring, and integrated kidney care services. DaVita emphasizes value-based care and multidisciplinary care coordination to expand PD adoption. | Increases access to home-based dialysis, improves patient engagement and treatment adherence, and supports personalized care pathways. Integrated care models reduce hospitalization rates, improve long-term patient outcomes, and enhance overall healthcare cost efficiency. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | PERITONEAL DIALYSIS MACHINES (Type) |
| Forecast Period | 2026-2031 |
| Growth Rate | CAGR of 6% from 2026 to 2031 |
| Largest Segment | PRODUCTS (Offering) |
| Market Size Base Year (Billions) | ~USD 10.58 (2026) |
| Revenue Forecast (Billions) | ~USD 14.16 (2031) |
| Segments Covered | Offering, Type, Modality, Disease Indication, End User |
5 segment dimensions are covered across the global market.
The UK peritoneal dialysis market is estimated at $138.0 million in 2026.
The UK peritoneal dialysis market is projected to reach $179.6 million by 2031.
The UK peritoneal dialysis market is expected to grow at a compound annual growth rate (CAGR) of 5.4% from 2026 to 2031.
The UK's NHS supports peritoneal dialysis as a cost-effective alternative to hemodialysis that promotes patient autonomy and improves quality of life through home-based treatment.
Key growth drivers include rising chronic kidney disease prevalence, an aging population, technological innovations, improved patient training programs, and favorable NHS reimbursement policies.
The study involved major activities in estimating the current market size for the peritoneal dialysis market. Exhaustive secondary research was done to collect information on the Peritoneal dialysis market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the Peritoneal dialysis market.
This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and companies’ house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the Peritoneal dialysis market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
In the primary research process, various supply- and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, VPs/Managing Directors, Marketing Heads/Directors, Sales Directors, Marketing/Sales Managers, Regional/Area Sales Managers, Export/Import Heads/Managers, and Other Peritoneal dialysis Market Related Personnel from various companies and organizations operating in the Peritoneal dialysis market. Primary sources from the demand side included Vice Presidents, C-level Executives, Department Heads, Enterprises, Individuals, Supply Management Team of Hospitals, Clinic Personnel, and Laboratory Technicians.
Breakdown of Primary Interviews

Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.
Note 2: Other primary roles include sales, marketing, and product management.
Note 3: Companies are classified into tiers based on their total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Both top-down and bottom-up approaches were used to estimate and validate the total size of the Peritoneal dialysis market. These methods were also used extensively to estimate the sizes of various market subsegments. The research methodology used to estimate the market size includes the following:

The entire market was split into three segments when the market size was determined. Data triangulation and market breakdown were used as needed to complete the market engineering process and derive precise statistics for all segments.
Approach for deriving the market size and estimating market growth.
Using secondary data from paid and unpaid sources, the market rankings for the major players were determined through a thorough analysis of their Peritoneal dialysis sales. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.
Phototherapy involves the utilization of a specific wavelength of light for the treatment of various medical conditions (such as psoriasis, vitiligo, acne vulgaris, neonatal jaundice, cancer, and eczema) through exposure of the affected area of the body to a light source.
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Full forecast, segment splits, and company analysis for all Peritoneal Dialysis Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report